At a glance
ClinicalIndex Comparison RecordN/ACompleted· 117 enrolled
Drug / intervention
lotrafilcon B contact lensdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Study of Lens Performance of a Monthly Replacement Lens at Two Weeks and Four Weeks
In Brief
A clinical study evaluating lotrafilcon B contact lens for Myopia and 2 related conditions. Completed, enrolled 117 participants.
Detailed Summary
The purpose of this study is to compare the overall performance of a monthly replacement contact lens when worn for one month and when worn for two weeks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Astigmatism, Presbyopia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
First PostedFeb 2011
Primary CompletionApr 2011
TodayJul 2026
First PostedFeb 10, 2011
Enrollment StartDec 1, 2010
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.4 years ago
Interventions
lotrafilcon B contact lensdevice
Commercially marketed, silicone hydrogel contact lens worn bilaterally on a daily wear basis for up to 30 days with a two week and four week evaluation visit.